At the Swiss Nano Convention 2018, a new initiative designed to assist the transfer from invention to innovation has been revealed. contactpointnano.ch, an independent, national platform will pool the scientific and regulatory knowledge and expertise on the safe handling of synthetic nanomaterials available in Switzerland.
Medication for the unborn child
Our team has succeeded in developing a new three-dimensional cell model of the human placental barrier. The "model organ" can quickly and reliably deliver new information on the intake of substances, such as nano-particles, by the placental barrier and on any possible toxic effects for the unborn child. This knowledge can also be used in the future for the development of new approaches to therapy during pregnancy. more
10th European Placenta Perfusion Workshop
We hosted the 10th European Placenta Perfusion Workshop at Empa in St.Gallen. The workshop was a great success!
Best Poster Award to Tina Bürki
The Empa Particles@Barrier group head by Tina Bürki, Particles-Biology Lab, won the Best Poster Award at the 10th CLINAM Submit for their work ‘A novel organotypic 3D microtissue model to assess nanoparticle uptake and effects at the human placental barrier’. This international conference gathered world-leading scientists in the field of clinical nano- and targeted medicine to discuss novel concepts in medicine and their translation to the clinics. We cordially congratulate.
Empa Innovation Award 2016
Congratulations to Cordula Hirsch from our lab for receiving the Empa Innovation Award together with Gaan Sabyasachi and his team! Well done!
Matthias Rösslein awarded
Matthias Rösslein, Senior Scientist of the Particles-Biology Interactions Laboratory has been awarded by the Materials Measurement Laboratory (MML) Accolades Program of National Institute of Standards and Technology (NIST) for his work elaborated together with Marc Salit (NIST) ‘providing tools to enable confidence and reliability in genome-scale gene expression measurements crucial to disease diagnosis and treatment’. This award is created to recognize exemplary work of individuals or teams in areas of high strategic interest and benefit to MML and NIST. ‘Our Associates are fundamental to the success of our projects and we look forward to continued cooperation with Empa.’ stated Dr. Laurie Locascio, Director of the Materials Measurement Laboratory NIST.
Best Poster at CLINAM
The Empa Particles@Barrier group head by Tina Bürki, Particles-Biology Lab, won the Best Poster Award at the 9th CLINAM Submit for their work ‘Studying nanoparticles translocation and effects at the human placenta barrier using ex vivo and advanced in vitro model systems’. This international conference gathered world-leading scientists in the field of clinical nano- and targeted medicine to discuss novel concepts in medicine and their translation to the clinics. We cordially congratulate!
Opening of KRISS Joint Research Office
The cooperation between Empa and the Korea Research Institute of Standards and Science (KRISS) in the field of nano-safety research has been intensified further by the inauguration of a KRISS “branch” in St. Gallen. On 23 July last year, Empa CEO Gian-Luca Bona and KRISS Vice-President Hyun Min Park signed a Memorandum of Understanding for a closer collaboration between the two institutes.
Unser Beitrag in der Fernsehsendung Einstein vom 28. Januar 2016
Training in the US
We are organizing an international symposium on the topic “2D Nano-Materials” with focus on:
- synthesis and properties of 2D materials
- regulation, standardization and safety
- applications and industry perspectives
Launch of first European nanomedicine characterization lab
Empa, the Swiss Federal Laboratories for Materials Science and Technology, is part of the «European Nanomedicine Characterization Laboratory», a European project funded by the EU framework program «Horizon 2020». Its goal is ...